# BBIO: BridgeBio Pharma, Inc. Common Stock

- Industry: Pharmaceutical Preparations
- Current price: $66.61
- Price updated: Sep 19, 2026
- Total congressional trades: 2
- Politicians trading: 1
- Last traded: Sep 22, 2025
- Source: https://tryglasshouse.ai/companies/BBIO.md

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

# Congressional trading history

- Page: 1 of 1
- Results: 2 of 2
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Sep 22, 2025, disclosed Oct 10, 2025
- Market context: $51.54 at trade, $66.61 current (+29.24%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/2c585354-915e-4d6a-a3bd-8096b25f3548.md

## 2. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Aug 8, 2025, disclosed Sep 12, 2025
- Market context: $46.58 at trade, $66.61 current (+43.00%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/eff14d32-cf4b-4b85-b6e9-c0c3bca69cbf.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.